Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_assertion type Assertion NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_head.
- NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_assertion description "[In addition, the positive rate of CIP2A expression was higher in stage IIB osteosarcoma than stage IIA cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_provenance.
- NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_assertion evidence source_evidence_literature NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_provenance.
- NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_assertion SIO_000772 24014087 NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_provenance.
- NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_assertion wasDerivedFrom befree-2016 NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_provenance.
- NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_assertion wasGeneratedBy ECO_0000203 NP1108502.RAfriTeL38lpPNLMU5iY4h89-cmxfJG5iIXieVtBA3bNA130_provenance.